Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
SPIbio/Idarubicin (hydrochloride)/1 mg/14176188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

SPIbio/Idarubicin (hydrochloride)/1 mg/14176

  • Product Overview
  • Data
  • Downloads
  • About Cayman
Territorial Availability: Available through Bertin Pharma only in Europe
Synonyms:
  • (7S,9S)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione, monohydrochloride
Correlated keywords:
  • 58957-92-9 antibiotics cancers natural products analogs leukemias therapeutics therapy anthracycline antiobiotics DNA topoisomerase II cancers cells NSC-256439 NSC256439 NSCs 256439 idamycin DMDs zavedos
Product Overview:Idarubicin is a 4-demethoxy analog of the leukemia therapeutic daunorubicin (Item No. 14159). Both are anthracycline antibiotics which intercalate in DNA and inhibit topoisomerase II, resulting in cancer cell cytotoxicity at low concentrations (IC50 = 20-120 nM for idarubicin).{22870,22872,22871} Idarubicin is effective in combination therapy for the treatment of different types of leukemia.{22873,22874}
Size 1 mg
Shipping dry ice
Stability Store at -20 degrees; shelf life 730 days
CAS Number 57852-57-0
Molecular Formula C26H27NO9 • HCl
SMILES O=C(C1=C2C=CC=C1)C3=C(C(O)=C(C[C@@](O)(C(C)=O)C[C@@H]4O[C@]5([H])O[C@@H](C)[C@@H](O)[C@@H](N)C5)C4=C3O)C2=O.Cl
Molecular Weight 534
Formulation A crystalline solid
Purity ≥98%
Custom Code 2907.29
UNSPSC code 12352100
Technical File
MSDS

Cayman Chemical"s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

AccreditationsISO/IEC 17025:2005ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

新闻动态
行业前沿
技术文章
最新产品